Physician Assistant, Medical · Redding, CA
NPI
1235205931
Since 2006
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2107 Airpark Dr
Redding, CA, 96001
Phone (530) 241-1111
Groups this clinician bills Medicare through
Medicare paid, 2024
$109K
2,794 services
Medicare patients, 2024
874
Average age 74
Drug cost, 2024
$1.6M
670 prescriptions
Company payments, 2025
$724
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lindsay L Miller was code 99213 (office e&m - established), 813 times for 616 patients. In total Lindsay L Miller billed 2,794 services in 59 codes, and Medicare paid $109K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-08-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 813 | 616 | $48.43 | $39K |
| 17003 Destruction Skin Lesion | Office | 756 | 196 | $4.21 | $3,184 |
| 17000 Destruction Skin Lesion | Office | 396 | 286 | $36.41 | $14K |
| 99212 Office E&M - Established | Office | 238 | 194 | $33.69 | $8,019 |
| 99214 Office E&M - Established | Office | 169 | 142 | $72.06 | $12K |
| 99203 Office E&M - New | Office | 55 | 55 | $57.13 | $3,142 |
| 17261 Destruction Skin Lesion | Office | 37 | 34 | $81.82 | $3,027 |
| 17110 Destruction Skin Lesion | Office | 30 | 27 | $65.61 | $1,968 |
| 17280 Destruction Skin Lesion | Office | 24 | 23 | $86.39 | $2,073 |
| 17281 Destruction Skin Lesion | Office | 23 | 19 | $117.30 | $2,698 |
| 99202 Office E&M - New | Office | 17 | 17 | $27.00 | $459 |
| 11900 Skin | Office | 15 | 11 | $26.58 | $399 |
| 17271 Destruction Skin Lesion | Office | 13 | 12 | $107.25 | $1,394 |
| 11102 Skin Biopsy | Office | 12 | 12 | $56.41 | $677 |
By year: 2022 $91K for 2,175 services; 2023 $109K for 2,514 services; 2024 $109K for 2,794 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lindsay L Miller prescribed most often to Medicare patients was Triamcinolone Acetonide, with 51 prescriptions and refills. In total Lindsay L Miller wrote 670 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 51 | 58 | 38 | $556 |
| Metronidazole Generic | 47 | 57 | 21 | $2,041 |
| Adbry Tralokinumab-Ldrm | 40 | 40 | Under 11 | $122K |
| Taltz Autoinjector Ixekizumab | 40 | 40 | Under 11 | $268K |
| Doxycycline Hyclate Generic | 28 | 35 | 15 | $366 |
| Ivermectin Generic | 26 | 27 | 13 | $5,423 |
| Opzelura Ruxolitinib Phosphate | 26 | 26 | Under 11 | $52K |
| Dupixent Pen Dupilumab | 22 | 22 | Under 11 | $82K |
| Tretinoin Generic | 21 | 23 | Under 11 | $1,669 |
| Imiquimod Generic | 20 | 23 | Under 11 | $5,647 |
| Dutasteride Generic | 20 | 38 | Under 11 | $726 |
| Valacyclovir Valacyclovir Hcl | 18 | 22 | Under 11 | $381 |
| Skyrizi Pen Risankizumab-Rzaa | 17 | 48 | Under 11 | $350K |
| Fluorouracil Generic | 16 | 16 | 16 | $1,071 |
| Alclometasone Dipropionate Generic | 15 | 16 | 12 | $489 |
Brand drugs: 271 claims; generic drugs: 399 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lindsay L Miller $724 ($724 in general payments such as food, travel and fees) from 9 companies. The largest payer was Janssen Biotech, Inc. with $304.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 3 | $304 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $144 |
| Abbvie Inc. ABBV | 3 | $73.11 |
| Lilly USA, LLC LLY | 3 | $54.72 |
| Galderma Laboratories, L.P. GALD.SW | 3 | $46.64 |
| LEO Pharma Inc. | 2 | $39.26 |
| Incyte Corporation INCY | 1 | $25.64 |
| Genzyme Corporation SNY | 1 | $22.48 |
| Sumitomo Pharma America, Inc. 4506.T | 1 | $14.98 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.